Sartorius Aktiengesellschaft (BIT:1SRT)

Market Cap	14.75B +19.3%
Revenue (ttm)	3.58B +3.3%
Net Income	196.10M +88.4%
EPS	n/a
Shares Out	n/a
PE Ratio	75.20
Forward PE	37.46
Dividend	0.73 (0.37%)
Ex-Dividend Date	Mar 27, 2026

Volume	n/a
Open	n/a
Previous Close	194.40
Day's Range	n/a
52-Week Range	156.40 - 209.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About BIT:1SRT

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture...

• Industry: Laboratory Analytical Instruments
• Founded: 1870
• Employees: 14,279
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SRT

Financial Performance

In 2025, BIT:1SRT's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 5, 2026

Data Sources Report a data error